Instrument Inactif

Autres langues Cadence Pharmaceuticals, Inc.

Actions

US12738T1007

Produits pharmaceutiques

Cours en clôture Nasdaq
- ^USD	-

Autres langues

06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma
28/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
17/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connection With the Sale of the Company to Mallinckrodt plc
14/02/14	Cadence Pharmaceuticals, Inc. : SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.
13/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors in Connection with the Sale of the Company to Mallinckrodt plc -- CADX
12/02/14	Cadence Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.
11/02/14	Cadence Pharmaceuticals, Inc. : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders
11/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX
11/02/14	Cadence Pharmaceuticals, Inc. : INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX
11/02/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Shareholders Notice: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Proposed Sale of Cadence Pharmaceuticals, Inc. to Mallinckrodt plc
13/01/14	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
09/12/13	Cadence Pharmaceuticals, Inc. : New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences
26/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The 25th Annual Piper Jaffray Healthcare Conference On December 4, 2013
20/11/13	Cadence Pharmaceuticals, Inc. : Drug Milestones, Favorable Ruling, Official Statement, and Quarterly Report - Research Report on BioMarin, Vanda, Cadence, Prana, and Biostar
15/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Positive Outcome In OFIRMEV® Patent Litigation
08/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
05/11/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
29/10/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
04/09/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals' CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
15/08/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Comments on USPTO's Non-Final, Initial Office Action on Reexamination of Patent
15/08/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
06/08/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
31/07/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
24/07/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
03/07/13	Cadence Pharmaceuticals, Inc. : Cadence Pharmaceuticals To Present At The 8th Annual JMP Securities Healthcare Conference On July 9, 2013